Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Menzella

Showing results (21-30 of 132) with videos related to

Pageof 14
Sort By:
Expert Review of Respiratory Medicine|March 24, 2022
Home-based treatment of biologics for asthma: who, what, where, when and whyFrancesco Menzella, Matteo Fontana, Patrizia Ruggiero, et al.
Expert Opinion on Biological Therapy|April 30, 2019
Reduction of oral corticosteroids in patients with severe eosinophilic asthma treated with Benralizumab: could it represent a marker of treatment efficacy?Francesco Menzella, Manuela Latorre, Patrizia Ruggiero, et al.
Journal of Asthma and Allergy|September 19, 2017
Innovative treatments for severe refractory asthma: how to choose the right option for the right patient?Francesco Menzella, Carla Galeone, Francesca Bertolini, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|July 10, 2018
Heat-induced necrosis after bronchial thermoplasty: a new concern?Francesco Menzella, Mirco Lusuardi, Carla Galeone, et al.
Multidisciplinary Respiratory Medicine|September 7, 2018
Acute respiratory failure as presentation of late-onset Pompe disease complicating the diagnostic process as a labyrinth: a case reportFrancesco Menzella, Luca Codeluppi, Mirco Lusuardi, et al.
Therapeutics and Clinical Risk Management|June 30, 2016
Clinical usefulness of mepolizumab in severe eosinophilic asthmaFrancesco Menzella, Mirco Lusuardi, Gloria Montanari, et al.
Pulmonary Pharmacology & Therapeutics|December 21, 2019
Biologics and Bronchial Thermoplasty for severe refractory asthma treatment: From eligibility criteria to real practice. A cross-sectional studyFrancesco Menzella, Carla Galeone, Patrizia Ruggiero, et al.
Human Vaccines & Immunotherapeutics|August 19, 2022
Expert consensus on the role of OM-85 in the management of recurrent respiratory infections: A Delphi studySusanna Esposito, Michele Cassano, Renato Cutrera, et al.
Advances in Therapy|July 11, 2014
A budget impact analysis of bronchial thermoplasty for severe asthma in clinical practiceFrancesco Menzella, Luigi Zucchi, Roberto Piro, et al.
Therapeutic Advances in Chronic Disease|November 3, 2016
Mepolizumab for severe refractory eosinophilic asthma: evidence to date and clinical potentialFrancesco Menzella, Mirco Lusuardi, Carla Galeone, et al.
Pageof 14

Showing results (21-30 of 132) with videos related to

Sort By:
Pageof 14
Expert Review of Respiratory Medicine|March 24, 2022
Home-based treatment of biologics for asthma: who, what, where, when and whyFrancesco Menzella, Matteo Fontana, Patrizia Ruggiero, et al.
Expert Opinion on Biological Therapy|April 30, 2019
Reduction of oral corticosteroids in patients with severe eosinophilic asthma treated with Benralizumab: could it represent a marker of treatment efficacy?Francesco Menzella, Manuela Latorre, Patrizia Ruggiero, et al.
Journal of Asthma and Allergy|September 19, 2017
Innovative treatments for severe refractory asthma: how to choose the right option for the right patient?Francesco Menzella, Carla Galeone, Francesca Bertolini, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|July 10, 2018
Heat-induced necrosis after bronchial thermoplasty: a new concern?Francesco Menzella, Mirco Lusuardi, Carla Galeone, et al.
Multidisciplinary Respiratory Medicine|September 7, 2018
Acute respiratory failure as presentation of late-onset Pompe disease complicating the diagnostic process as a labyrinth: a case reportFrancesco Menzella, Luca Codeluppi, Mirco Lusuardi, et al.
Therapeutics and Clinical Risk Management|June 30, 2016
Clinical usefulness of mepolizumab in severe eosinophilic asthmaFrancesco Menzella, Mirco Lusuardi, Gloria Montanari, et al.
Pulmonary Pharmacology & Therapeutics|December 21, 2019
Biologics and Bronchial Thermoplasty for severe refractory asthma treatment: From eligibility criteria to real practice. A cross-sectional studyFrancesco Menzella, Carla Galeone, Patrizia Ruggiero, et al.
Human Vaccines & Immunotherapeutics|August 19, 2022
Expert consensus on the role of OM-85 in the management of recurrent respiratory infections: A Delphi studySusanna Esposito, Michele Cassano, Renato Cutrera, et al.
Advances in Therapy|July 11, 2014
A budget impact analysis of bronchial thermoplasty for severe asthma in clinical practiceFrancesco Menzella, Luigi Zucchi, Roberto Piro, et al.
Therapeutic Advances in Chronic Disease|November 3, 2016
Mepolizumab for severe refractory eosinophilic asthma: evidence to date and clinical potentialFrancesco Menzella, Mirco Lusuardi, Carla Galeone, et al.
Pageof 14